Articles with "anticancer therapeutic" as a keyword



(-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia

Sign Up to like & get
recommendations!
Published in 2019 at "Drug Delivery"

DOI: 10.1080/10717544.2019.1672830

Abstract: Abstract Realgar and (-)-Epigallocatechin-3-gallate (EGCG) are natural medicines that inhibit cancer cell growth, resulting in inhibition of formation and development of tumors. The anticancer effects of realgar and EGCG were greatly improved following formulation as… read more here.

Keywords: egcg rnps; epigallocatechin gallate; egcg; realgar ... See more keywords
Photo by enginakyurt from unsplash

FNC: An Advanced Anticancer Therapeutic or Just an Underdog?

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.820647

Abstract: Azvudine (FNC) is a novel cytidine analogue that has both antiviral and anticancer activities. This minireview focuses on its underlying molecular mechanisms of suppressing viral life cycle and cancer cell growth and discusses applications of… read more here.

Keywords: oncology; anticancer therapeutic; advanced anticancer; fnc ... See more keywords
Photo by enginakyurt from unsplash

Selected Monocyclic Monoterpenes and Their Derivatives as Effective Anticancer Therapeutic Agents

Sign Up to like & get
recommendations!
Published in 2021 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms22094763

Abstract: Terpenes—a diverse group of secondary metabolites—constitute the largest class of natural products abundant in almost every plant species. The properties of concrete terpenes and essential oils have been intensively studied due to their widespread use… read more here.

Keywords: monoterpenes derivatives; anticancer therapeutic; effective anticancer; monocyclic monoterpenes ... See more keywords
Photo from wikipedia

Anticancer Therapeutic Strategies Targeting p53 Aggregation

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms231911023

Abstract: p53 is a tumor suppressor protein that is mutated in more than 50% of cancer cases. When mutated, it frequently results in p53 oncogenic gain of function (GOF), resulting in a greater tendency to aggregate… read more here.

Keywords: aggregation; anticancer therapeutic; therapeutic strategies; p53 aggregation ... See more keywords